May 27, 2020
InMed Releases CBN Preclinical Results in Glaucoma
May 19, 2020
InMed Pharmaceuticals Continues to Strengthen Biosynthesis Patent Family
May 14, 2020
InMed Pharmaceuticals Reports Third Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update
May 08, 2020
InMed Pharmaceuticals to Report Third Quarter Fiscal 2020 Financial Results and Business Update on May 14, 2020
May 06, 2020
Cannabics Pharmaceuticals Files Provisional Patent on Composition and Method for Treating Colon Cancer With Cannabinoids
May 05, 2020
InMed and Almac Group Developing Improved Cannabinoid Production Methods
May 04, 2020
Nextleaf Solutions Granted German Patent for CBD Oil Extraction
Apr 30, 2020
InMed Receives CTA Approval for Second Phase 1 Clinical Trial with INM-755
Apr 13, 2020
Cannabics Pharmaceuticals Develops Novel Cannabis Formulation for the Treatment of Colon Cancer
Apr 01, 2020
Two Bears Farm Affirms Hemp Cannabinoid and Terpene Studies - Stress and Anxiety Can Put Even More Strain Upon Our Immune Systems
Mar 25, 2020
Cannabics Pharmaceuticals Study Shows Complex Combinatorial Anti-tumor Activity of Cannabinoids
Mar 12, 2020
100% THC-Free Hemp & CBD Oil Company's 2020 Launch
Mar 12, 2020
Willow Biosciences Announces Cannabinoid Scale-Up and Expedited Path to Commercialization
Mar 10, 2020
InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
Mar 09, 2020
Senzer Secures US Clinical Data Package for the Treatment of Chemotherapy Induced Adverse Events
Mar 02, 2020
Cannabics Pharmaceuticals Reveals Different Extraction Methods Result in Differential Necrotic Effects of Cannabis on Gastrointestinal Cancer Cells
Mar 02, 2020
Cannabics Pharmaceuticals Reveals Different Extraction Methods Result in Differential Necrotic Effects of Cannabis on Gastrointestinal Cancer Cells
Feb 27, 2020
Nextleaf Solutions Prepares for Potential Pharmaceutical Participation with Prodrug Patent
Feb 20, 2020
Health Canada-DEA Approves MMJ International Holdings To Ship THC
Feb 14, 2020
InMed Pharmaceuticals Reports Second Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update